Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-8-5
pubmed:databankReference
pubmed:abstractText
The human adipocyte-specific apM-1 gene encodes a secretory protein of the adipose tissue that has been suggested to play a role in the pathogenesis of obesity. The regulation of apM-1 was studied along adipocyte differentiation. While apM-1-mRNA and apM-1 protein were absent in preadipocytes and in 48 h differentiated adipocytes, they were found upregulated from day 4 to day 9 of adipocyte differentiation as shown by RNase protection assay and Western blot analysis. These data indicate that apM-1 may be a late marker of adipocyte differentiation. In human sera apM-1 protein is also detectable by Western blots using a polyclonal antibody raised against a synthetic peptide sequence of the human apM-1. The genomic structure of the human apM-1 gene together with a total of 2.7 kb of the 5'-flanking region with putative transcription factor binding sites is presented. Interestingly, sequence comparisons link the apM-1 gene to the family of TNF's and to genes expressed in activated T-cells. The chromosomal localization of apM-1 was investigated by FISH and mapped to human chromosome 1q21.3-1q23, a region that was identified as a susceptibility locus for Familial Combined Hyperlipidaemia (FCH) and polygenic NIDDM. These data and the chromosomal localization on chromosome 1q21.3-q23 raises the possibility that apM-1 as an adipocyte-specific secretory protein may play a role in the pathogenesis of FCH and associated insulin resistance. Exon- and intron-specific primer sequences are presented as a basis for mutation screening of patients affected with FCH.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0006-291X
pubmed:author
pubmed:copyrightInfo
Copyright 1999 Academic Press.
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
260
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
416-25
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:10403784-3T3 Cells, pubmed-meshheading:10403784-Adiponectin, pubmed-meshheading:10403784-Amino Acid Sequence, pubmed-meshheading:10403784-Animals, pubmed-meshheading:10403784-Base Sequence, pubmed-meshheading:10403784-Chromosome Mapping, pubmed-meshheading:10403784-Chromosomes, Human, Pair 1, pubmed-meshheading:10403784-Exons, pubmed-meshheading:10403784-Genetic Linkage, pubmed-meshheading:10403784-Genetic Predisposition to Disease, pubmed-meshheading:10403784-Humans, pubmed-meshheading:10403784-Hyperlipidemia, Familial Combined, pubmed-meshheading:10403784-In Situ Hybridization, Fluorescence, pubmed-meshheading:10403784-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:10403784-Introns, pubmed-meshheading:10403784-Lymphocyte Activation, pubmed-meshheading:10403784-Mice, pubmed-meshheading:10403784-Molecular Sequence Data, pubmed-meshheading:10403784-Promoter Regions, Genetic, pubmed-meshheading:10403784-Proteins, pubmed-meshheading:10403784-RNA, Messenger, pubmed-meshheading:10403784-Sequence Homology, Nucleic Acid, pubmed-meshheading:10403784-T-Lymphocytes, pubmed-meshheading:10403784-Tumor Necrosis Factor-alpha
pubmed:year
1999
pubmed:articleTitle
The human apM-1, an adipocyte-specific gene linked to the family of TNF's and to genes expressed in activated T cells, is mapped to chromosome 1q21.3-q23, a susceptibility locus identified for familial combined hyperlipidaemia (FCH).
pubmed:affiliation
Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany.
pubmed:publicationType
Journal Article